Effects of Cannabinoids on T-cell Function and Resistance to Infection

Modulation of Gut-Specific Mechanisms by Chronic Δ9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis

(2014) Patricia E. Molina et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Histone Modifications Are Associated with Δ9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses

(2014) Xiaoming Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders

(2014) Vishnudutt Purohit et al.   Journal of Neuroimmune Pharmacology

Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

(2013) Rebecca Hartzell Robinson et al.   Journal of Neuroimmune Pharmacology

Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes

(2013) Julie T. Castaneda et al.   Journal of Neuroimmune Pharmacology

Differential Modulation by Delta9-Tetrahydrocannabinol (∆9-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4+ T cells

(2012) Thitirat Ngaotepprutaram et al.   Journal of Neuroimmune Pharmacology

Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions

(2012) S. H. Ramirez et al.   JOURNAL OF NEUROSCIENCE

Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells

(2012) Cristina Maria Costantino et al.   PLoS One

Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.

(2011) Peter J. Winsauer et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

(2011) Sreemanti Basu et al.   IMMUNOLOGIC RESEARCH

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

(2011) Peer W. F. Karmaus et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Δ9-Tetrahydrocannabinol Suppresses Cytotoxic T Lymphocyte Function Independent of CB1 and CB2, Disrupting Early Activation Events

(2011) Peer W. F. Karmaus et al.   Journal of Neuroimmune Pharmacology

Chronic Δ-9-tetrahydrocannabinol Administration Increases Lymphocyte CXCR4 Expression in Rhesus Macaques

(2011) Nicole J. LeCapitaine et al.   Journal of Neuroimmune Pharmacology

Cannabinoid Neuroimmune Modulation of SIV Disease

(2011) Patricia E. Molina et al.   Journal of Neuroimmune Pharmacology

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10−/− mice by attenuating the activation of T cells and promoting their apoptosis

(2011) Udai P. Singh et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis

(2010) Amélie Servettaz et al.   AMERICAN JOURNAL OF PATHOLOGY

Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus

(2010) Hartwig P. Huemer et al.   IMMUNOBIOLOGY

Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS

(2010) Santhi Gorantla et al.   Journal of Neuroimmune Pharmacology

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis

(2009) Alfiya Akhmetshina et al.   ARTHRITIS AND RHEUMATISM

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

(2009) Sadiye Amcaoglu Rieder et al.   IMMUNOBIOLOGY

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

(2009) Martin A. Storr et al.   INFLAMMATORY BOWEL DISEASES

Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling

(2009) Christine Börner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury

(2009) Ming Zhang et al.   MICROVASCULAR RESEARCH

Suppression of T cell costimulator ICOS by  9-tetrahydrocannabinol

(2008) H. Lu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9 -tetrahydrocannabinol

(2008) Alison E. B. Springs et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection

(2008) Catherine A. Newton et al.   Journal of Neuroimmune Pharmacology

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

(2008) V. L. Hegde et al.   MOLECULAR PHARMACOLOGY

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY